MAI Capital Management’s RxSight RXST Stock Holding History

MAI Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-608	Closed	-$3.75K	–	4202
2026 Q1	$3.75K	Buy	608 +602	+10,033%	+$5K	﹤0.01%	3654
2025 Q4	$63	Buy	+6	New	+$60	﹤0.01%	4214

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

MAI Capital Management's RXST Position: Q2 2026 in Review

MAI Capital Management sold out of RxSight (RXST) in Q2 2026, closing a stake of 608 shares — an estimated $3.75K sold.

MAI Capital Management first reported a position in RXST in Q4 2025 and held it in 2 quarters. The position peaked at $3.75K in Q1 2026. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

MAI Capital Management reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 608 RxSight shares in Q2 2026, an estimated $3.75K.
MAI Capital Management first reported a position in RxSight in Q4 2025 and held it in 2 quarters.
MAI Capital Management's RxSight position peaked at $3.75K in Q1 2026.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.